Nicolai Doliba · Philadelphia, Pennsylvania
Dr. Nicolai Doliba's lab at the University of Pennsylvania focuses on understanding the early cellular changes that occur in the progression of Type 1 Diabetes (T1D). The research particularly investigates how alpha cells, responsible for glucagon secretion, function in individuals at high genetic risk for T1D and how their abnormalities might influence the disease's progression. By examining cell signaling pathways and energy metabolism, the lab aims to uncover potential intervention points to delay or prevent T1D development.
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.